Skip to main content
Table of Contents
Print

Why do adolescents with ADHD pick up substance use earlier? 

Author: Victoria Rowe, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

According to NHS guidance, adolescents with ADHD are more prone to risk-taking, impulsive decisions, and emotional swings, all key drivers of earlier experimentation with substances. These behaviours are closely linked to executive-function differences, which make it harder for young people to pause, anticipate harm, or assess long-term consequences. The NHS also notes that difficulties with attention and emotional regulation can lower resilience in social situations, increasing susceptibility to peer influence. 

NICE’s NG87 guideline highlights that ADHD is associated with altered dopamine signalling and reward processing. For some young people, substances can feel intensely stimulating or calming, increasing the likelihood of trying them earlier than peers. 

Emotional and social pressures 

The Royal College of Psychiatrists reports that many adolescents with ADHD also experience anxiety, low self-esteem, or conduct difficulties, all of which raise risk for early substance use. In some cases, teens may use substances to cope with emotional distress, frustration, or social rejection. 

WHO and UK taskforce findings further emphasise the influence of environment: peer pressure, academic exclusion, inconsistent support at home, and stigma surrounding ADHD can all accelerate early experimentation. These wider social factors combine neurobiological vulnerability, creating a higher-risk pathway. 

The role of reward pathways 

Emerging research indicates that ADHD-related differences in dopamine and reward systems make some teens more sensitive to the effects of substances. Studies published via PMC show that early subjective rewards, such as feeling calmer, more confident, or more focused, can reinforce early use. When combined with impulsivity and emotional dysregulation, this creates a faster route to experimentation and, for some, dependency. 

When co-occurring conditions amplify risk 

Systematic reviews highlight that ADHD combined with conditions such as oppositional defiant disorder, conduct problems, trauma exposure, or anxiety markedly increases early substance use risk. Evidence from recent longitudinal studies confirms higher likelihood of early use of alcohol, nicotine, cannabis, and multi-substance experimentation by ages 13–15. 

Protective factors that help 

The evidence also highlights several important protective factors: 

  • Early psychoeducation for families and schools 
  • Structure, predictable routines, and clear boundaries 
  • Emotional support and behavioural interventions 
  • Early ADHD treatment, which studies in BMJ and The Lancet link to reduced risk of substance misuse, self-harm, and accidental injury 
  • Strong relationships with trusted adults 
  • Supportive school environments and safeguarding policies 

If you are concerned about a young person 

Understanding that ADHD creates additional vulnerability, biologically, emotionally, and socially, can help families take proactive steps. NICE recommends early behavioural support, psychoeducation, and professional assessment where needed. 

For families exploring diagnostic clarity or structured support, private providers such as ADHD Certify offer assessments aligned with NICE standards. 

Takeaway 

Adolescents with ADHD tend to initiate substance use earlier because of a combination of neurobiological sensitivity, impulsivity, emotional pressures, and environmental risk factors. With early support, clear routines, strong relationships, and timely treatment, families can significantly reduce these risks and help young people thrive. 

Victoria Rowe, MSc
Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS
Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy. 

Categories